MICHELLE STONE: Open Payments
NPI 1417499716 · MT STERLING, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 22 payments from 12 companies in 2025. Trend: 2023 $182 · 2024 $316 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $59 |
| ABBVIE INC. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Lilly USA, LLC | 3 | $48 |
| Abbott Laboratories | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $21 |
Products named: UBRELVY, CAPLYTA, Ozempic, FREESTYLE LIBRE, AIRSUPRA, MOUNJARO, JARDIANCE, HETLIOZ.
Industry payments across KY — which companies pay providers there.
